Literature DB >> 25157807

Structural insights into the interaction of blood coagulation co-factor VIIIa with factor IXa: a computational protein-protein docking and molecular dynamics refinement study.

Divi Venkateswarlu1.   

Abstract

Coagulation factor X (FX) zymogen activation by factor IXa (FIXa) enzyme plays a critical role in the middle-phase of coagulation cascade. The activation process is catalytically inert and requires FIXa binding and complex formation with co-factor VIIIa (FVIIIa). In order to understand the structural details of the FVIIIa:FIXa complex, we employed knowledge-driven protein-protein docking and aqueous-phase MD refinement methods to develop a stable structural complex between FVIIIa and FIXa. The model shows that all four domains of FIXa wrap across FVIIIa that spans the co-factor binding surface of A2, A3 and C1 domains. The region surrounding the 558-helix of the A2-domain of FVIIIa is predicted to be the key interaction site with the helical segments of Lys293-Lys301 and Asp332-Arg338 residues of the serine-protease domain of FIXa. The hydrophobic helical stack between the GLA and EGF1 domains of FIXa is predicted to be primary interacting region with the A3-C2 domain interface of FVIIIa.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Blood clotting; Factor IXa; Factor VIIIa; Molecular dynamics; Protein–protein docking; Tenase complex

Mesh:

Substances:

Year:  2014        PMID: 25157807      PMCID: PMC4179997          DOI: 10.1016/j.bbrc.2014.08.078

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  23 in total

1.  Factor IXa:factor VIIIa interaction. helix 330-338 of factor ixa interacts with residues 558-565 and spatially adjacent regions of the a2 subunit of factor VIIIa.

Authors:  S P Bajaj; A E Schmidt; A Mathur; K Padmanabhan; D Zhong; M Mastri; P J Fay
Journal:  J Biol Chem       Date:  2001-02-14       Impact factor: 5.157

2.  Hydrophobic contact between the two epidermal growth factor-like domains of blood coagulation factor IX contributes to enzymatic activity.

Authors:  P H Celie; P J Lenting; K Mertens
Journal:  J Biol Chem       Date:  2000-01-07       Impact factor: 5.157

3.  UCSF Chimera--a visualization system for exploratory research and analysis.

Authors:  Eric F Pettersen; Thomas D Goddard; Conrad C Huang; Gregory S Couch; Daniel M Greenblatt; Elaine C Meng; Thomas E Ferrin
Journal:  J Comput Chem       Date:  2004-10       Impact factor: 3.376

4.  Gene for human factor X: a blood coagulation factor whose gene organization is essentially identical with that of factor IX and protein C.

Authors:  S P Leytus; D C Foster; K Kurachi; E W Davie
Journal:  Biochemistry       Date:  1986-09-09       Impact factor: 3.162

Review 5.  Structure, function, and molecular defects of factor IX.

Authors:  A R Thompson
Journal:  Blood       Date:  1986-03       Impact factor: 22.113

6.  Expression and characterization of human factor IX and factor IX-factor X chimeras in mouse C127 cells.

Authors:  S W Lin; K J Smith; D Welsch; D W Stafford
Journal:  J Biol Chem       Date:  1990-01-05       Impact factor: 5.157

7.  The active site of blood coagulation factor Xa. Its distance from the phospholipid surface and its conformational sensitivity to components of the prothrombinase complex.

Authors:  E J Husten; C T Esmon; A E Johnson
Journal:  J Biol Chem       Date:  1987-09-25       Impact factor: 5.157

8.  The Gla domain of factor IXa binds to factor VIIIa in the tenase complex.

Authors:  Mark D Blostein; Barbara C Furie; Isabelle Rajotte; Bruce Furie
Journal:  J Biol Chem       Date:  2003-06-02       Impact factor: 5.157

9.  Crystal structure of Mg2+- and Ca2+-bound Gla domain of factor IX complexed with binding protein.

Authors:  Yasuo Shikamoto; Takashi Morita; Zui Fujimoto; Hiroshi Mizuno
Journal:  J Biol Chem       Date:  2003-04-14       Impact factor: 5.157

10.  Active site selective labeling of serine proteases with spectroscopic probes using thioester peptide chloromethyl ketones: demonstration of thrombin labeling using N alpha-[(acetylthio)acetyl]-D-Phe-Pro-Arg-CH2Cl.

Authors:  P E Bock
Journal:  Biochemistry       Date:  1988-08-23       Impact factor: 3.162

View more
  5 in total

1.  Exosites expedite blood coagulation.

Authors:  Maria Luiza Vilela Oliva; Ingrid Dreveny; Jonas Emsley
Journal:  J Biol Chem       Date:  2020-11-06       Impact factor: 5.157

2.  A proximity-based in silico approach to identify redox-labile disulfide bonds: The example of FVIII.

Authors:  Andrea Arsiccio; Clive Metcalfe; Roberto Pisano; Sanj Raut; Carmen Coxon
Journal:  PLoS One       Date:  2022-02-07       Impact factor: 3.240

3.  Activated protein C has a regulatory role in factor VIII function.

Authors:  Amelia R Wilhelm; Nicole A Parsons; Benjamin J Samelson-Jones; Robert J Davidson; Charles T Esmon; Rodney M Camire; Lindsey A George
Journal:  Blood       Date:  2021-05-06       Impact factor: 22.113

Review 4.  The Molecular Basis of FIX Deficiency in Hemophilia B.

Authors:  Guomin Shen; Meng Gao; Qing Cao; Weikai Li
Journal:  Int J Mol Sci       Date:  2022-03-02       Impact factor: 5.923

5.  SAXS analysis of the intrinsic tenase complex bound to a lipid nanodisc highlights intermolecular contacts between factors VIIIa/IXa.

Authors:  Kenneth C Childers; Shaun C Peters; Pete Lollar; Harold Trent Spencer; Christopher B Doering; Paul C Spiegel
Journal:  Blood Adv       Date:  2022-06-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.